U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C17H26N2O.ClH.H2O
Molecular Weight 328.877
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ROPIVACAINE HYDROCHLORIDE

SMILES

O.Cl.CCCN1CCCC[C@H]1C(=O)NC2=C(C)C=CC=C2C

InChI

InChIKey=VSHFRHVKMYGBJL-CKUXDGONSA-N
InChI=1S/C17H26N2O.ClH.H2O/c1-4-11-19-12-6-5-10-15(19)17(20)18-16-13(2)8-7-9-14(16)3;;/h7-9,15H,4-6,10-12H2,1-3H3,(H,18,20);1H;1H2/t15-;;/m0../s1

HIDE SMILES / InChI

Approval Year

Unknown
86413
Name Type Language
ROPIVACAINE HYDROCHLORIDE
ORANGE BOOK   USP   USP-RS   VANDF  
Common Name English
ROPIVACAINE HYDROCHLORIDE MONOHYDRATE [EP IMPURITY]
Common Name English
(S)-(-)-1-PROPYLPIPERIDINE-2-CARBOXYLIC ACID (2,6-DIMETHYLPHENYL)AMIDE HYDROCHLORIDE MONOHYDRATE
Systematic Name English
ROPIVACAINE HYDROCHLORIDE MONOHYDRATE [MI]
Common Name English
ROPIVACAINE HYDROCHLORIDE HYDRATE
JAN  
Common Name English
ROPIVACAINE HCL
Common Name English
ROPIVACAINE HYDROCHLORIDE MONOHYDRATE [EP MONOGRAPH]
Common Name English
(S)-(-)-1-PROPYL-2',6'-PIPECOLOXYLIDINE HYDROCHLORIDE MONOHYDRATE
Common Name English
ROPIVACAINE HYDROCHLORIDE [VANDF]
Common Name English
ROPIVACAINE HYDROCHLORIDE MONOHYDRATE
EP   MI   ORANGE BOOK   WHO-DD  
Common Name English
Ropivacaine hydrochloride monohydrate [WHO-DD]
Common Name English
ROPIVACAINE HYDROCHLORIDE MONOHYDRATE [ORANGE BOOK]
Common Name English
NAROPIN
Brand Name English
ROPIVACAINE HYDROCHLORIDE [USP MONOGRAPH]
Common Name English
ROPIVACAINE HYDROCHLORIDE HYDRATE [JAN]
Common Name English
ROPIVACAINE HYDROCHLORIDE [ORANGE BOOK]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C245
Created by admin on Fri Dec 15 15:35:36 UTC 2023 , Edited by admin on Fri Dec 15 15:35:36 UTC 2023
Code System Code Type Description
RS_ITEM_NUM
1605500
Created by admin on Fri Dec 15 15:35:36 UTC 2023 , Edited by admin on Fri Dec 15 15:35:36 UTC 2023
PRIMARY
DAILYMED
V910P86109
Created by admin on Fri Dec 15 15:35:36 UTC 2023 , Edited by admin on Fri Dec 15 15:35:36 UTC 2023
PRIMARY
CHEBI
60803
Created by admin on Fri Dec 15 15:35:36 UTC 2023 , Edited by admin on Fri Dec 15 15:35:36 UTC 2023
PRIMARY
PUBCHEM
6918111
Created by admin on Fri Dec 15 15:35:36 UTC 2023 , Edited by admin on Fri Dec 15 15:35:36 UTC 2023
PRIMARY
NCI_THESAURUS
C52198
Created by admin on Fri Dec 15 15:35:36 UTC 2023 , Edited by admin on Fri Dec 15 15:35:36 UTC 2023
PRIMARY
CHEBI
34954
Created by admin on Fri Dec 15 15:35:36 UTC 2023 , Edited by admin on Fri Dec 15 15:35:36 UTC 2023
PRIMARY
RXCUI
236539
Created by admin on Fri Dec 15 15:35:36 UTC 2023 , Edited by admin on Fri Dec 15 15:35:36 UTC 2023
ALTERNATIVE
EVMPD
SUB22590
Created by admin on Fri Dec 15 15:35:36 UTC 2023 , Edited by admin on Fri Dec 15 15:35:36 UTC 2023
PRIMARY
SMS_ID
100000090606
Created by admin on Fri Dec 15 15:35:36 UTC 2023 , Edited by admin on Fri Dec 15 15:35:36 UTC 2023
PRIMARY
FDA UNII
V910P86109
Created by admin on Fri Dec 15 15:35:36 UTC 2023 , Edited by admin on Fri Dec 15 15:35:36 UTC 2023
PRIMARY
EPA CompTox
DTXSID80927544
Created by admin on Fri Dec 15 15:35:36 UTC 2023 , Edited by admin on Fri Dec 15 15:35:36 UTC 2023
PRIMARY
CAS
132112-35-7
Created by admin on Fri Dec 15 15:35:36 UTC 2023 , Edited by admin on Fri Dec 15 15:35:36 UTC 2023
PRIMARY
ChEMBL
CHEMBL1077896
Created by admin on Fri Dec 15 15:35:36 UTC 2023 , Edited by admin on Fri Dec 15 15:35:36 UTC 2023
PRIMARY
EVMPD
SUB04264MIG
Created by admin on Fri Dec 15 15:35:36 UTC 2023 , Edited by admin on Fri Dec 15 15:35:36 UTC 2023
PRIMARY
RXCUI
1298851
Created by admin on Fri Dec 15 15:35:36 UTC 2023 , Edited by admin on Fri Dec 15 15:35:36 UTC 2023
PRIMARY
DRUG BANK
DBSALT000902
Created by admin on Fri Dec 15 15:35:36 UTC 2023 , Edited by admin on Fri Dec 15 15:35:36 UTC 2023
PRIMARY
MERCK INDEX
m9659
Created by admin on Fri Dec 15 15:35:36 UTC 2023 , Edited by admin on Fri Dec 15 15:35:36 UTC 2023
PRIMARY Merck Index
ACTIVE MOIETY
Structure of ROPIVACAINE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966